Skip to main content

Table 2 Comparison of treatment groups at baseline

From: A randomized placebo-controlled trial of the efficacy and safety of a terbinafine, florfenicol and betamethasone topical ear formulation in dogs for the treatment of bacterial and/or fungal otitis externa

  

Osurnia

Placebo

P-Value

Number

 

190

94

 

Age

(mean (range); yrs

6.1 (0.3–16.4)

6.1 (0.3–15.8)

0.9097

Body weight

<  40 lbs.; N (%)

78 (41%)

41 (44%)

0.8617

40–79 lbs.; n (%)

64 (34%)

32 (34%)

≥80 lbs.; n (%)

48 (25%)

21 (22%)

Gender

F:M ratio

90:100 = 0.9

52:42 = 1.2

0.2564

Ears affected

One ear; n (%)

17 (9%)

7 (7%)

0.8217

Two ears; n (%)

173 (91%)

87 (93%)

History of otitis

Acute; n (%)

47 (25%)

29 (31%)

0.5436

Subchronic; n (%)

73 (38%)

32 (34%)

Chronic; n (%)

70 (37%)

33 (35%)

Exudate Type

Erythematous/ceruminous; n (%)

158 (83%)

78 (83%)

1.000

Suppurative; n (%)

32 (17%)

16 (17%)

Frequency of Otitis

Recurrent otitis; n (%)

22 (12%)

9 (10%)

0.6894

Hearing Loss

Can hear at Day 0; n (%)

181 (97%)

90 (96%)

0.4846